Acute stroke reperfusion therapy trends in the expanded treatment window era.
about
Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.Paramedic Perspectives on Barriers to Prehospital Acute Stroke Recognition.Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury.Simulated Bench Testing to Evaluate the Mechanical Performance of New Carotid Stents.Emergency Dispatcher Stroke Recognition: Associations with Downstream Care.
P2860
Acute stroke reperfusion therapy trends in the expanded treatment window era.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Acute stroke reperfusion therapy trends in the expanded treatment window era.
@ast
Acute stroke reperfusion therapy trends in the expanded treatment window era.
@en
type
label
Acute stroke reperfusion therapy trends in the expanded treatment window era.
@ast
Acute stroke reperfusion therapy trends in the expanded treatment window era.
@en
prefLabel
Acute stroke reperfusion therapy trends in the expanded treatment window era.
@ast
Acute stroke reperfusion therapy trends in the expanded treatment window era.
@en
P2093
P2860
P1476
Acute stroke reperfusion therapy trends in the expanded treatment window era
@en
P2093
Albert W Tsai
Ganesh Asaithambi
James M Peacock
Kamakshi Lakshminarayan
Russell V Luepker
P2860
P304
P356
10.1016/J.JSTROKECEREBROVASDIS.2014.04.023
P577
2014-08-23T00:00:00Z